CoChat

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies

Shen, Jinze, Wang, Qurui, Mao, Yunan, Gao, Wei, Duan, Shiwei · 2023 · MedComm
Cited by 62

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Tumor suppressor p53 can transcriptionally activate downstream genes in response to stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis, and other biological responses. p53 has seven functional domains and 12 splice isoforms, and different domains and subtypes play different roles. The activation and inactivation of p53 are finely regulated and are associated with phosphorylation/acetylation modification and ubiquitination modification, respectively. Abnormal activation of p53 is closely related to the occurrence and development of cancer. While targeted therapy of the p53 signaling pathway is still in its early stages and only a few drugs or treatments have entered clinical trials, the development of new drugs and ongoing clinical trials are expected to lead to the widespread use of p53 signaling‐targeted therapy in cancer treatment in the future. TRIAP1 is a novel p53 downstream inhibitor of apoptosis. TRIAP1 is the homolog of yeast mitochondrial intermembrane protein MDM35, which can play a tumor‐promoting role by blocking the mitochondria‐dependent apoptosis pathway. This work provides a systematic overview of recent basic research and clinical progress in the p53 signaling pathway and proposes that TRIAP1 is an important therapeutic target downstream of p53 signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mco2.288

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 376

  1. 10.3390/cancers14235733 · DOI
  2. 10.1016/0016-5085(94)90431-6 · DOI
  3. 10.1016/j.tcb.2009.10.002 · DOI · Paper page
  4. 10.1016/j.tibs.2015.04.007 · DOI
  5. 10.1016/j.tig.2022.02.010 · DOI · Paper page
  6. 10.1038/nrc1954 · DOI · Paper page
  7. 10.1007/s00018-022-04505-w · DOI
  8. 10.4161/cc.4.9.1981 · DOI · Paper page
  9. 10.3389/fcell.2022.818744 · DOI
  10. 10.1038/sj.emboj.7600608 · DOI · Paper page
  11. 10.1200/JCO.2005.05.019 · DOI · Paper page
  12. 10.1016/j.celrep.2019.07.001 · DOI · Paper page
  13. 10.3389/fonc.2022.1006959 · DOI
  14. 10.1016/j.cell.2022.10.004 · DOI · Paper page
  15. 10.1080/15548627.2021.2008752 · DOI
  16. 10.1016/j.molcel.2021.08.023 · DOI
  17. 10.1021/jacs.1c06169 · DOI
  18. 10.1186/s13045-021-01169-0 · DOI · Paper page
  19. 10.1186/s40164-022-00317-7 · DOI · Paper page
  20. 10.1016/j.lfs.2022.121361 · DOI
  21. 10.1038/s41467-023-36755-y · DOI
  22. 10.1002/hep.30807 · DOI
  23. 10.1200/JCO.2002.20.4.883 · DOI
  24. 10.1016/j.cbpa.2022.102230 · DOI
  25. 10.3390/ijms232113287 · DOI
  26. 10.3389/fonc.2022.1000677 · DOI
  27. 10.1158/2159-8290.CD-22-1131 · DOI
  28. 10.1126/scitranslmed.aay2163 · DOI
  29. 10.1097/JTO.0000000000000584 · DOI
  30. 10.1093/jnci/djp376 · DOI
  31. 10.1093/jmcb/mjaa040 · DOI · Paper page
  32. 10.1038/s41573-022-00571-8 · DOI · Paper page
  33. Li W, 2022, Early biomarkers associated with P53 signaling for acute radiation injury, Life (Basel), 12
  34. 10.3389/fgene.2022.855355 · doi:10.3389/fgene.2022.855355
  35. 10.1159/000501633 · DOI
  36. 10.1371/journal.pgen.1000129 · DOI · Paper page
  37. 10.1158/2159-8290.CD-22-0332 · DOI · Paper page
  38. 10.3390/ijms21010013 · DOI
  39. 10.3390/biom12111558 · DOI
  40. 10.2174/138920107783018444 · DOI · Paper page
  41. 10.1038/sj.cdd.4401914 · DOI · Paper page
  42. 10.1038/s41419-022-05349-9 · DOI
  43. 10.1038/onc.2010.266 · DOI
  44. 10.4161/cc.8.8.8251 · DOI · Paper page
  45. 10.1126/sciadv.abi6684 · DOI
  46. 10.3390/cancers12113422 · DOI
  47. 10.1016/j.febslet.2010.10.005 · DOI · Paper page
  48. 10.1038/cdd.2014.73 · DOI
  49. 10.1038/ncomms5706 · DOI
  50. 10.1038/s41375-022-01634-w · DOI · Paper page
  51. 10.1038/s41467-021-20928-8 · DOI
  52. 10.1021/acs.accounts.7b00473 · DOI
  53. 10.1016/j.molcel.2019.03.032 · DOI
  54. 10.3390/cancers11081079 · DOI
  55. 10.21037/atm.2020.02.142 · DOI
  56. 10.1016/j.drup.2019.100671 · DOI · Paper page
  57. 10.1161/CIRCULATIONAHA.113.005224 · DOI
  58. 10.1093/nar/gkab222 · DOI
  59. 10.1038/s41556-020-0559-z · DOI · Paper page
  60. 10.1101/cshperspect.a000950 · DOI · Paper page
  61. 10.1101/cshperspect.a026047 · DOI · Paper page
  62. 10.1038/s41417-022-00513-x · DOI
  63. 10.1182/blood.2020009997 · DOI
  64. 10.1016/j.molcel.2020.07.021 · DOI
  65. 10.1016/j.ccr.2006.10.012 · DOI
  66. 10.1186/1476-4598-12-35 · DOI
  67. 10.1038/s41467-022-35089-5 · DOI
  68. 10.1126/scisignal.aao4170 · DOI · Paper page
  69. 10.1038/onc.2009.71 · DOI · Paper page
  70. 10.1016/S0092-8674(00)00073-8 · DOI · Paper page
  71. 10.1038/onc.2010.115 · DOI
  72. 10.1186/s13046-022-02288-3 · DOI
  73. 10.18632/oncotarget.9046 · doi:10.18632/oncotarget.9046
  74. 10.1136/gutjnl-2020-321386 · DOI
  75. 10.1038/s41417-020-0175-x · DOI
  76. 10.7150/thno.21963 · DOI
  77. 10.1158/0008-5472.CAN-20-1804 · DOI
  78. 10.1074/jbc.M210696200 · DOI · Paper page
  79. Scolnick DM, 1997, CREB‐binding protein and p300/CBP‐associated factor are transcriptional coactivators of the p53 tumor suppressor protein, Cancer Res, 57, 3693
  80. 10.1158/1078-0432.CCR-05-1230 · DOI
  81. 10.1016/j.arr.2018.02.004 · DOI · Paper page
  82. 10.1016/j.canlet.2015.04.015 · DOI
  83. 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  84. 10.1016/j.celrep.2016.09.022 · DOI · Paper page
  85. 10.1016/j.bbrc.2014.08.122 · DOI
  86. 10.1371/journal.pone.0115401 · DOI · Paper page
  87. 10.1158/0008-5472.CAN-18-2357 · DOI
  88. 10.3390/ijms222413198 · DOI
  89. 10.1007/2789_2008_105 · DOI
  90. 10.1038/nature02514 · DOI · Paper page
  91. 10.1038/nsmb.1521 · DOI · Paper page
  92. 10.1038/emboj.2011.125 · DOI
  93. 10.1016/j.omtm.2021.01.015 · DOI
  94. 10.1016/j.bbrc.2007.11.176 · doi:10.1016/j.bbrc.2007.11.176
  95. 10.1021/acs.chemrev.6b00737 · DOI · Paper page
  96. 10.1593/neo.06439 · DOI
  97. 10.1007/s12026-022-09334-4 · doi:10.1007/s12026-022-09334-4
  98. 10.1038/s41467-019-09471-9 · DOI
  99. 10.1016/j.molcel.2006.05.016 · DOI · Paper page
  100. 10.3390/cancers14112806 · DOI
  101. 10.1002/anie.202215704 · DOI
  102. 10.1002/advs.202206169 · DOI
  103. 10.1016/S1470-2045(22)00633-7 · DOI
  104. 10.4161/cc.21235 · DOI
  105. 10.1093/nar/gkt012 · DOI · Paper page
  106. 10.1016/j.cell.2007.03.048 · DOI · Paper page
  107. 10.3390/ijms23158187 · DOI
  108. 10.1016/j.tig.2020.12.005 · DOI · Paper page
  109. 10.1016/j.arr.2009.04.005 · DOI
  110. 10.1016/j.drup.2022.100805 · DOI
  111. 10.1146/annurev-biochem-052521-035949 · DOI
  112. 10.7150/jca.81027 · DOI
  113. 10.1371/journal.pgen.1010012 · DOI
  114. 10.1093/narcan/zcab026 · DOI
  115. 10.1038/s41418-022-00962-9 · DOI
  116. 10.1038/s41589-023-01267-9 · DOI
  117. 10.1038/s41586-019-1678-1 · DOI · Paper page
  118. 10.1038/s41467-018-05567-w · DOI · Paper page
  119. 10.15252/embj.201797833 · DOI
  120. 10.1016/j.ijbiomac.2023.123180 · DOI
  121. 10.1016/j.cbpa.2022.102259 · DOI
  122. 10.1016/j.bbrc.2019.06.152 · DOI
  123. 10.1016/j.bbrc.2021.01.074 · DOI
  124. 10.7150/ijbs.69784 · DOI
  125. 10.1038/leu.2016.293 · DOI
  126. 10.1007/s11033-010-0099-x · DOI
  127. 10.1038/s41598-017-17973-z · DOI
  128. 10.1158/0008-5472.CAN-14-2430 · DOI
  129. 10.1016/S0378-1119(01)00543-1 · DOI
  130. 10.1128/MCB.00821-08 · DOI
  131. 10.1016/j.tig.2021.03.001 · DOI
  132. 10.1016/j.tig.2020.01.001 · DOI
  133. 10.3390/cancers13143415 · DOI
  134. 10.1016/j.yexcr.2006.01.020 · DOI
  135. 10.1128/MMBR.64.2.435-459.2000 · DOI · Paper page
  136. 10.1080/15548627.2022.2062112 · DOI · Paper page
  137. 10.1016/j.ejmech.2022.115020 · DOI
  138. 10.1182/blood.2019003439 · DOI
  139. 10.1016/j.semcdb.2022.04.001 · DOI
  140. 10.1016/j.molmed.2013.07.005 · DOI · Paper page
  141. 10.1146/annurev-biochem-082411-113907 · DOI · Paper page
  142. 10.3390/cells7050036 · DOI
  143. 10.3892/ijo.2014.2377 · DOI
  144. 10.1016/S0968-0004(02)02166-7 · DOI · Paper page
  145. 10.1016/j.febslet.2010.09.019 · DOI
  146. 10.26508/lsa.202201472 · DOI
  147. 10.18632/oncotarget.2081 · DOI
  148. 10.1007/s00280-019-03923-1 · DOI
  149. 10.1016/j.febslet.2010.06.027 · DOI
  150. 10.1002/hep.24329 · DOI
  151. 10.1038/sj.emboj.7600836 · DOI
  152. 10.1016/j.molcel.2013.05.006 · DOI
  153. 10.1038/onc.2009.314 · DOI
  154. 10.1038/cdd.2010.168 · DOI
  155. 10.1161/01.RES.0000253975.76198.ff · DOI · Paper page
  156. 10.1161/CIRCULATIONAHA.113.002434 · DOI · Paper page
  157. 10.1182/blood-2005-08-3273 · DOI · Paper page
  158. 10.1016/j.phrs.2023.106696 · DOI
  159. 10.1021/acs.jmedchem.1c00940 · DOI · Paper page
  160. 10.1007/s12032-022-01929-z · DOI
  161. 10.1073/pnas.0908027106 · DOI · Paper page
  162. 10.1093/hmg/ddh165 · DOI
  163. 10.1186/1471-2121-3-30 · DOI
  164. 10.1016/j.jep.2022.116046 · DOI
  165. Jiang W, 2020, Hsa‐miR‐217 inhibits the proliferation, migration, and invasion in non‐small cell lung cancer cells via targeting SIRT1 and P53/KAI1 signaling, Balkan Med J, 37, 208
  166. 10.1371/journal.pone.0016427 · DOI
  167. 10.1038/oncsis.2017.12 · DOI
  168. 10.1080/15384101.2016.1261767 · DOI
  169. 10.18632/aging.203459 · doi:10.18632/aging.203459
  170. 10.1080/08830185.2020.1795153 · DOI
  171. Wu CE, 2022, In vitro and in vivo study of GSK2830371 and RG7388 combination in liver adenocarcinoma, Am J Cancer Res, 12, 4399
  172. 10.1016/j.ccr.2007.08.033 · DOI · Paper page
  173. 10.1016/j.tcb.2020.12.011 · DOI · Paper page
  174. 10.1016/j.ccell.2018.12.012 · DOI · Paper page
  175. 10.1038/s41568-022-00535-5 · DOI · Paper page
  176. 10.1002/smll.202205166 · DOI
  177. 10.3390/cancers15020551 · DOI
  178. 10.1007/s12282-018-0913-1 · DOI
  179. 10.1016/j.ando.2019.04.010 · DOI
  180. 10.1158/0008-5472.CAN-04-3995 · DOI · Paper page
  181. 10.1023/A:1023725029589 · DOI · Paper page
  182. 10.1200/JCO.2002.09.147 · DOI
  183. 10.1200/JCO.1999.17.10.3150 · doi:10.1200/jco.1999.17.10.3150
  184. 10.3389/fcell.2022.1012179 · doi:10.3389/fcell.2022.1012179
  185. 10.3390/ijms21030870 · DOI
  186. 10.3390/ijms21103670 · DOI
  187. 10.1007/978-1-4614-8289-5_6 · DOI
  188. 10.1016/j.tig.2019.11.005 · DOI · Paper page
  189. 10.1111/eos.12685 · DOI
  190. 10.21873/anticanres.15510 · DOI
  191. Aljabal G, 2020, 14‐3‐3sigma and its modulators in cancer, Pharmaceuticals (Basel), 13, 10.3390/ph13120441 · DOI
  192. 10.1111/pin.13147 · DOI
  193. 10.1158/1078-0432.CCR-03-0510 · DOI
  194. 10.1016/j.cca.2020.09.009 · DOI
  195. 10.1128/MCB.23.20.7096-7107.2003 · DOI · Paper page
  196. 10.1158/2159-8290.CD-22-0244 · DOI
  197. 10.1002/adma.202207384 · DOI
  198. 10.1016/j.bbcan.2005.11.002 · DOI · Paper page
  199. 10.1016/j.cca.2013.05.002 · DOI · Paper page
  200. 10.1016/j.semcancer.2022.09.006 · DOI

200 of 376 shown

Metadata

Authors
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S.
Venue
MedComm
Publisher
Wiley
Published
2023-05-28
Volume
4
Issue
3
ISSN
2688-2663
Cited by
62
References
44
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. https://app.cochat.ai/papers/10.1002/mco2.288
The paper
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023). Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. MedComm. https://doi.org/10.1002/mco2.288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.